Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193805-25-001195·Mersana Therapeutics, Inc.
Schedule 13G ownership disclosure
MERSANA THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 59045L106
Event date: 2025-06-30
- Filing-level shares
- 5,673,852.00
- Percent of class
- 4.55%
- Schonfeld Strategic Advisors LLC
Shares: 5,673,852.00 · Class: 4.55%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-25-001195
- Form type
- SCHEDULE 13G/A
- Filer
- Mersana Therapeutics, Inc.
- CIK
- CIK 1442836
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership